Life Sciences & Healthcare
Rapid transformation in the Life Sciences and Healthcare industry can require businesses to strike a balance between patient demands, market potential and policy compliance, while continuing to innovate. We create solutions that can help you to remain competitive in this constantly evolving market.
Where impact happens
Throughout the health ecosystem, you’ll find courageous and inspiring people who are committed to driving transformation, advancing health and leading a well-being revolution. Where you find innovators committed to sustainable progress, you find the Life Sciences & Healthcare practices of Deloitte member firms. Our leaders work side by side to orchestrate and deliver on the business of science and health. We bring trusted, flexible approaches that can foster innovation, harness new technologies, and formulate consumer-driven strategies to engineer a digitally enabled future of health - starting today.
Our Thinking
Empowering the Health Care workforce for a climate-resilient future
In this report, Project HOPE and Deloitte US have brought together frontline Healthcare workers, programme leaders, health system advisors, policy and advocacy professionals, community leaders and strategic relationships to collaborate on potential solutions for enhancing climate resilience.
Platform business models: Private Equity opportunities in the Life Sciences and Healthcare sector
Platform businesses are rewiring the traditional value chain. In nearly every industry, well-thought-out platform businesses typically beat traditional businesses because of superior unit economics and network effects.
Electronic Health Records Solution
Deloitte's Electronic Health Record (EHR) solution helps health systems execute Digital Transformation that shifts legacy models into modern best practices anchored on elevating the human experience.
A path toward health equity
The COVID-19 pandemic exposed a glaring disparity in global vaccine access. The World Economic Forum (WEF) and Deloitte have been collaborating to tackle this challenge by advocating for regionalised vaccine manufacturing ecosystems. This approach aims to revolutionise vaccine production and distribution, promoting equity and resilience in the face of future health crises.
Explore the Life Sciences & Healthcare industry
